387 Notably, the CKD-FIX study and the PERL trials demonstrated that allopurinol did not significantly slow the deterioration of estimated glomerular filtration rate (eGFR) in chronic kidney disease patients compared to placebo, over a span of 2 and 3 years, respectively
Patients experiencing persistent vomiting, severe abdominal pain, or signs of pancreatitis should seek immediate medical attention
Reporting the findings in JAMA Internal Medicine, the researchers including experts from Eli Lilly, the makers of Mounjaro, said participants who maintained the weight reduction to less than 25% regain at week 88 also maintained the benefits seen in central adiposity, triglycerides, non-HDL cholesterol, fasting insulin, and insulin resistance
"Caprelsa (vandetanib) Tablets, for Oral Use